These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23536483)

  • 61. Use of livers from hepatitis B core antibody positive donors in living donor liver transplantation.
    Yaprak O; Dayangac M; Balci D; Demirbas T; Yuzer Y; Tokat Y
    Hepatogastroenterology; 2010; 57(102-103):1268-71. PubMed ID: 21410070
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients.
    Buti M; Elefsiniotis I; Jardi R; Vargas V; Rodriguez-Frias F; Schapper M; Bonovas S; Esteban R
    J Hepatol; 2007 Sep; 47(3):366-72. PubMed ID: 17561304
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An Experiment of Nature: HBV-naive Recipients Receiving Liver Grafts With HBV Core Antibody-positive Donors Without Antiviral Prophylaxis.
    Fallahzadeh MA; Trotter JF
    Transplantation; 2020 Aug; 104(8):e245-e246. PubMed ID: 32732858
    [No Abstract]   [Full Text] [Related]  

  • 64. [A study on the treatment of chronic hepatitis B with YMDD mutation].
    Qiu YW; Jiang XH; Huang LH; Hu TH; Ding H; Jiang YM; Dai YX; Zhou M
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):171-4. PubMed ID: 19335977
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Successful treatment of hepatitis B virus infection and related cryoglobulinaemic purpura with nucleoside/nucleotide analogues.
    D'Amico E; Pace-Palitti V; Di Lembo E; Palazzi C
    Clin Exp Rheumatol; 2013; 31(1):155. PubMed ID: 23190931
    [No Abstract]   [Full Text] [Related]  

  • 66. Lamivudine compared with newer antivirals for prophylaxis of hepatitis B core antibody positive livers: a cost-effectiveness analysis.
    Wright AJ; Fishman JA; Chung RT
    Am J Transplant; 2014 Mar; 14(3):629-34. PubMed ID: 24460820
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatitis B therapy, hepatocellular carcinoma and HBsAg mutants.
    Marzano A; Marengo A; David E; Rizzetto M
    Dig Liver Dis; 2013 Jun; 45(6):525-7. PubMed ID: 23415581
    [No Abstract]   [Full Text] [Related]  

  • 68. The significance of enzyme immunoassay for the assessment of hepatitis B virus core-related antigen following liver transplantation.
    Fujimoto M; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Nagaoka S; Yatsuhashi H; Kanematsu T; Eguchi K
    Intern Med; 2009; 48(18):1577-83. PubMed ID: 19755758
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus.
    Ju W; Chen M; Guo Z; Wang D; Zhu X; Huang J; He X
    Exp Clin Transplant; 2013 Jun; 11(3):245-9. PubMed ID: 23176583
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Failure to treat hepatitis B virus infection with adefovir due to early selection of rtA181T mutation].
    Rodríguez Dominguez M; de la Loma GA; Moreira Vicente V; Mateos Lindemann M
    Med Clin (Barc); 2010 Apr; 134(10):468-9. PubMed ID: 19464708
    [No Abstract]   [Full Text] [Related]  

  • 71. [A Case of Fanconi's Syndrome Induced by Adefovir in Hepatitis Type B Patient].
    Watanabe K; Hashimoto S; Maoka T; Yamamoto R; Okamoto N; Koike T
    Nihon Naika Gakkai Zasshi; 2016 Jun; 105(6):1026-33. PubMed ID: 30168694
    [No Abstract]   [Full Text] [Related]  

  • 72. Reactivation of hepatitis B virus without core antibody.
    Silva-Pinto A; Andrade J; Araújo F; Santos L; Sarmento A
    J Clin Microbiol; 2015 Apr; 53(4):1434-5. PubMed ID: 25631798
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Attention-getting sexually transmitted diseases: Hepatitis B].
    Takahashi S; Chayama K
    Nihon Naika Gakkai Zasshi; 2007 Nov; 96(11):2450-5. PubMed ID: 18069297
    [No Abstract]   [Full Text] [Related]  

  • 74. Transplanting organs from hepatitis B positive donors: Is it safe? Is it ethical?
    Anwar N; Sherman KE
    J Viral Hepat; 2018 Oct; 25(10):1110-1115. PubMed ID: 29968277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [New management strategies for hepatitis B].
    Castelneau C; Boyer N; Marcellin P
    Gastroenterol Clin Biol; 2002 Feb; 26(2):120-2. PubMed ID: 11938061
    [No Abstract]   [Full Text] [Related]  

  • 76. Prophylaxis and treatment in liver transplantation. VII Consensus Document of the Spanish Society of Liver Transplantation.
    Fernández I; Pascasio JM; Colmenero J; ;
    Gastroenterol Hepatol; 2020 Mar; 43(3):169-177. PubMed ID: 32094045
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Is there risk of transmitting hepatitis B virus in accepting hepatitis B core antibody-positive donors for living related liver transplantation?
    Boyacioğlu S; Arslan H; Demirhan B; Gür G; Turan M; Haberal M
    Transplant Proc; 2001 Aug; 33(5):2802-3. PubMed ID: 11498165
    [No Abstract]   [Full Text] [Related]  

  • 78. Liver transplantation and de novo hepatitis B infection.
    Aldersley MA; Eglin RE; O'Grady JG
    Lancet; 1994 Mar; 343(8898):677. PubMed ID: 7906843
    [No Abstract]   [Full Text] [Related]  

  • 79. Oral antiviral therapy for hepatitis B: the case of besifovir, a new kid on the block with a long way to go.
    Lampertico P
    Gut; 2014 Jun; 63(6):869-70. PubMed ID: 24162592
    [No Abstract]   [Full Text] [Related]  

  • 80. Very late onset post-transplant diffuse large B cell lymphoma in a liver transplant recipient with hepatitis B: A case report.
    Yu F; Huang Y; Wang Y; Yu Z; Li X; Dong J
    Medicine (Baltimore); 2018 Nov; 97(44):e13063. PubMed ID: 30383683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.